Company / PP&E (Net)
Pasithea Therapeutics Corp. PP&E (Net) History
FY2021-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E (Net)
$378.8K
FY2022
5-year range
$20.1K / $378.8K
FY2021-FY2022
Trend
+1782.2%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
$378,783 in FY2022.
PP&E (Net) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, pp&e (net) increased 1782.2% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score -3.26 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E (Net)Value | YoY GrowthYoY |
|---|---|---|
| FY2022 | $378.8K | +1782.2% |
| FY2021 | $20.1K | - |
As of FY2022 · SEC 10-K · Updated Jun 28, 2026